PS Ratio: 18394.08

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 18394.08 is 4733% above its estimated 5-year average of 380.59, around the middle of its estimated 5-year range (134.97–31184.65).

As of 2026-10-06T17:31:12.715Z. 1196.72% above its estimated 12-month average of 1418.51.

CLDX PS Ratio Metrics

P/S vs. estimated history

At 18394.08, P/S is above its estimated 20-year median — higher than 99% of readings in its estimated 20-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The P/S ratio for CLDX stock is 18394.08.

Is Celldex Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 18394.08 is 4733% above its estimated 5-year average of 380.59, around the middle of its estimated 5-year range (134.97–31184.65).

What is the estimated TTM average P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The estimated TTM average P/S ratio for CLDX stock is 1418.51.

What is the estimated 3Y average P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The estimated 3Y average P/S ratio for CLDX stock is 343.72.

What is the estimated 5Y average P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The estimated 5Y average P/S ratio for CLDX stock is 380.59.

What is the estimated 10Y average P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The estimated 10Y average P/S ratio for CLDX stock is 179.19.

What is the estimated 15Y average P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The estimated 15Y average P/S ratio for CLDX stock is 205.80.

What is the estimated 20Y average P/S ratio for Celldex Therapeutics, Inc. (CLDX)?

The estimated 20Y average P/S ratio for CLDX stock is 149.67.

Showing the most recent 260 of 5,030 data points. The chart above shows the full history.

Related Metrics